Product Information
ICEC0942 is a protein kinase inhibitor that inhibits the activity of transcription factors. It has been shown to have anticancer effects in laboratory studies and in clinical trials on patients with cancer. ICEC0942 was found to be effective at a dose of 0.3 mg/kg, which is lower than the doses typically used for chemotherapy drugs. ICEC0942 also has a low toxicity profile and does not cause DNA damage or cellular dysregulation, which are common side effects of other cancer therapies.
Chemical properties
Technical inquiry about: 3D-FXC78954 ICEC0942 (CT7001)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
